Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
about
Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cellsGene therapy in clinical medicineThe significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer eventsProgress toward curing HIV infection with hematopoietic cell transplantationHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsIs genetic rescue of cystinosis an achievable treatment goal?Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disordersA lentiviral cDNA library employing lambda recombination used to clone an inhibitor of human immunodeficiency virus type 1-induced cell death.Efficient infection of primitive hematopoietic stem cells by modified adenovirus.Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitroEfficient gene transfer into human CD34(+) cells by a retargeted adenovirus vectorA murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytesNovel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression.Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.Limited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responsesLentiviral vectors: turning a deadly foe into a therapeutic agent.Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.Stem cell therapy and gene transfer for regeneration.Progress with retroviral gene vectors.Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells.Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vectorLarge animal models of hematopoietic stem cell gene therapy.The use of nonhuman primate models to improve gene transfer into haematopoietic stem cells.Gene therapy for genetic haematological disorders and immunodeficiencies.Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.In vivo assessment of gene delivery to keratinocytes by lentiviral vectorsRNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.Gene therapy for paediatric leukaemia.In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.Effective gene therapy with nonintegrating lentiviral vectors.Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.Medicine. A comeback for gene therapy.Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells.HIV infection of non-dividing cells: a divisive problem.Genetic therapy for HIV/AIDS.In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vectorMolecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313)Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes.Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain.Fetal gene therapy of alpha-thalassemia in a mouse model
P2860
Q24644026-0B4BBFB4-4907-4C0C-AFE8-E151DDD7225DQ24680275-C1E923B4-C9D9-4347-80CB-D6E608E35FAFQ24801168-57F82AB7-A5DC-401B-913C-002242FEBA6AQ26801269-68B360F6-5AE5-4371-9D5A-ADEFCD0E518DQ26859147-605C27BC-C7AE-40E2-8F7F-9907201067F7Q27023975-330D99F8-F531-4F25-A07A-65A6F6A96FEFQ30498317-43956100-8903-4D42-97ED-4FF82024AC30Q31116850-3E905CE0-C794-43BB-AE1C-098B567B4DDAQ33182157-069EE382-4083-4F6D-97B3-8FB4B5CB0751Q33787358-3D14DBA7-0B27-4E8C-B67F-416DCDB096B9Q33799667-5B54C4C1-3F49-4595-8297-44EC9F9DC287Q33802424-6BE2CBA8-5D5D-41CA-A36B-6FA5AE3E5DE3Q33808225-DB359E23-77F1-4106-867C-DF05DC6466EAQ33822226-64A8A79C-C15E-49C4-8046-1B4541FB27BDQ33838390-70AA6F86-E406-4563-98A7-46CCBE5E9858Q33840989-44148822-18E4-423D-9AB5-8B16EA4F922AQ33851061-E264B7E3-E127-4793-BF96-8B139614C7A9Q33886477-C1883AEC-3B77-4EEE-B37C-D8B9A06DAF8EQ33920752-D6692C25-9E45-4366-A9E8-5E915BB9D92CQ34019596-C1F78962-01EF-4308-93BF-84950C9DFE73Q34035474-89A88961-46B6-4082-82B1-3950478BCEE0Q34039922-B9C34FAA-B391-4E24-9709-FEAFAD699EFCQ34216668-DE427E47-0551-45E6-ACDD-06EA67CC0A8DQ34216698-EA6A082D-8820-45E2-98B1-8D5909B667B3Q34244510-80352AB2-340E-4903-986D-CB8160CFEEE8Q34328596-EED3771B-594D-4CB2-9522-241F6C26DD57Q34342598-45D9AD0A-A236-497C-8BEF-030D8469339BQ34451905-4C7B7E64-ED30-4290-AD5D-E8D56BC43A48Q34454464-0B5D9F97-9EAC-420D-85DF-78B6D658D6DAQ34496367-30902FF0-476E-4B13-90A3-1BB65B348B2DQ34587615-CFDFF3B9-CA92-4DD5-A461-06CDCBDA102CQ34613525-97B616A5-2D4C-4C6C-8F8D-1B0A54BFBBAFQ35038348-57C44FB4-51D7-4D40-BE7C-DA36AAF3A607Q35127406-48D0F676-96F5-4FE2-81E3-59162321C8AFQ35207524-5659C114-0F0F-4D5F-AD49-CB5168B15ECFQ35347210-3B1FF29D-0BC9-43DB-8B5A-D5F9C92B4B6EQ35585685-88D9E9C2-0B85-4FC4-A91E-FF0E483BC542Q35794301-AC5BB548-19D3-41D7-9648-C01D360C5857Q35802208-28C5189F-DAD1-4417-BA48-45B4EDCA25CEQ35829187-0057AC05-DC8F-49F2-B14F-603F5E6C082E
P2860
Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@ast
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@en
type
label
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@ast
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@en
prefLabel
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@ast
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@en
P2093
P2860
P356
P1476
Stable transduction of quiesce ...... HIV-1-based lentiviral vectors
@en
P2093
C T Jordan
G M Crooks
R Stripecke
P2860
P304
P356
10.1073/PNAS.96.6.2988
P407
P577
1999-03-01T00:00:00Z